Ansatbio Dynamicssp. z o.o. in liquidation
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2021-04-06
Share capital
10,000.00 PLN
Registered address
ul. Mazurska 23/2, 70-444 Szczecin, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 4 financial statements were filed late (the longest delay 94 days for 2024).
- 2025not filed
- 202417/10/2025
- 202319/08/2024
- 202215/07/2023
- 202114/10/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 9.58kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -6.57kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 15.21kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 5.19kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Antoni Katliński – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Rafał Tomasz Janickiage 40 | 50 | $1,350.62 | 50% |
Antoni Katlińskiage 66 | 50 | $1,350.62 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2021-06-08 to 2025-07-03.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 4, 2025 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| InventroS.A. | $12,176.61 | inventro.co | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| ArthecS.A. | $10,911.16 | arthec.eu | ||
| Vitagenumsp. z o.o. | $9,376.94 | vitagenum.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Meritrosp. z o.o. | $7,890.74 | meritro.com | ||
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Poltisssp. z o.o. | $3,843.72 | poltiss.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-21 | Name change (Ansatbio Dynamics Spółka Z Ograniczoną Odpowiedzialnością W Likwidacj → Ansatbio Dynamics Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2025-05-15 | Name change (Ansatbio Dynamics → Ansatbio Dynamics Spółka Z Ograniczoną Odpowiedzialnością W Likwidacj) | |
| 2025-02-26 | Liquidation opened | |
| 2021-04-06 | Entered in the register |
FAQ
The main business activity of Ansatbio Dynamics focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 6, 2021.
The headquarters is located at: ul. Mazurska 23, 70-444 Szczecin.
The share capital of the company is PLN 10,000 (approx. $2,701).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $9,577, representing a decrease of 49.3% compared to 2023.
No, the company recorded a net loss of $6,569 in 2024. For comparison, in 2023 the loss was $6,206, meaning the company increased its loss by 0.5%.
The largest operating cost category falls under employee remuneration. This category amounted to $11,789 in 2024, representing 77% of all operating expenses.
Last updated: 2026-04-25